We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.

Search Results

Showing 1-20 of 661 results
  1. Mixed-phenotype acute leukemia, T/megakaryoblastic: does it really exist?

    Mixed-phenotype acute leukemias (MPAL) account for < 4% of all cases of acute leukemias. These are a heterogeneous group of leukemias grouped...

    Neelum Mansoor, Omer Javed, ... Fatima Meraj in Journal of Hematopathology
    Article 01 March 2023
  2. Acute monocytic leukemia with KMT2A::LASP1 developed 9 months after diagnosis of acute megakaryoblastic leukemia in a 2-year-old boy

    Acute myeloid leukemia (AML) is known as one of the subsequent malignant neoplasms that can develop after cancer treatment, but it is difficult to...

    Takashi Fujita, Hiroko Fukushima, ... Hidetoshi Takada in International Journal of Hematology
    Article 14 June 2023
  3. Lineage switch in a pediatric patient with KMT2A-MLLT3 from acute megakaryoblastic leukemia to T cell acute lymphoblastic leukemia at the fourth relapse after allo-HSCT: with literature review

    We present a patient with acute megakaryoblastic leukemia (AMKL) harboring KMT2A-MLLT3 that converted to T cell acute lymphoblastic leukemia (T-ALL)...

    Li Gao, Jun Lu, ... Shaoyan Hu in International Journal of Hematology
    Article 06 December 2022
  4. Targeted Therapies in Pediatric Acute Myeloid Leukemia - Evolving Therapeutic Landscape

    Acute myeloid leukemia (AML) accounts for 25% of all leukemia diagnosis and is characterized by distinct cytogenetic and molecular profile. Advances...

    Eman T. Al-Antary, Avanti Gupte, Yaddanapudi Ravindranath in Indian Journal of Pediatrics
    Article 14 July 2023
  5. Comprehensive molecular understanding of pediatric acute myeloid leukemia

    Pediatric acute myeloid leukemia (AML) is a heterogeneous disease with various genetic abnormalities. Recent advances in genetic analysis have...

    Article 18 January 2023
  6. Megakaryoblastic leukemia: a study on novel role of clinically significant long non-coding RNA signatures in megakaryocyte development during treatment with phorbol ester

    Acute megakaryocytic leukemia (AMKL) is one of the rarest sub-types of acute myeloid leukemia (AML). AMKL is characterized by high proliferation of...

    Swati Dahariya, Sanjeev Raghuwanshi, ... Ravi Kumar Gutti in Cancer Immunology, Immunotherapy
    Article 23 April 2021
  7. Acute myeloid leukemia with rare recurring translocations—an overview of the entities included in the international consensus classification

    Two different systems exist for subclassification of acute myeloid leukemia (AML); the World Health Organization (WHO) Classification and the...

    Synne D. Rørvik, Synne Torkildsen, ... Tor Henrik Anderson Tvedt in Annals of Hematology
    Article Open access 06 March 2024
  8. Diagnostic challenge in mixed phenotype acute leukemia with T/megakaryocyte or T/myeloid lineages accompanied by t(3;3)

    Background

    The diagnosis of mixed phenotype acute leukemia (MPAL) with T/megakaryocyte or T/myeloid lineages accompanied by t(3;3) is always a...

    Yannan Jia, Dong Lin, ... Yingchang Mi in Diagnostic Pathology
    Article Open access 05 October 2022
  9. Downregulation of MIR100HG Induces Apoptosis in Human Megakaryoblastic Leukemia Cells

    Long noncoding ribonucleic acids (lncRNAs) are ribonucleic acid (RNA) molecules longer than 200 nucleotides without protein-coding capacity. Several...

    Parisa Bagheri, Mohammadreza Sharifi, Ava Ghadiri in Indian Journal of Hematology and Blood Transfusion
    Article 24 July 2020
  10. Recent advances in targeted therapies in acute myeloid leukemia

    Acute myeloid leukemia (AML) is the most common acute leukemia in adults. While survival for younger patients over the last several decades has...

    Rahul S. Bhansali, Keith W. Pratz, Catherine Lai in Journal of Hematology & Oncology
    Article Open access 25 March 2023
  11. A blastic plasmacytoid dendritic cell neoplasm-like immunophenotype is negatively associated with CEBPA bZIP mutation and predicts unfavorable prognosis in acute myeloid leukemia

    Blastic plasmacytoid dendritic cell neoplasm (BPDCN) is a rare and aggressive myeloid malignancy which characteristically expresses an atypical...

    Juanjuan Song, Weiya Li, ... Hu Zhou in Annals of Hematology
    Article 06 January 2024
  12. Cytogenetics analysis as the central point of genetic testing in acute myeloid leukemia (AML): a laboratory perspective for clinical applications

    Chromosomal abnormalities in acute myeloid leukemia (AML) have significantly contributed to scientific understanding of its molecular pathogenesis,...

    Aliaa Arina Rosli, Adam Azlan, ... Emmanuel Jairaj Moses in Clinical and Experimental Medicine
    Article 13 October 2022
  13. The International Consensus Classification of acute myeloid leukemia

    Acute myeloid leukemias (AMLs) are overlap** hematological neoplasms associated with rapid onset, progressive, and frequently chemo-resistant...

    Olga K. Weinberg, Anna Porwit, ... Daniel A. Arber in Virchows Archiv
    Article 20 October 2022
  14. Xeroderma pigmentosum and acute myeloid leukemia: a case report 

    Background

    Xeroderma pigmentosum is a rare inherited disease characterized by extreme hypersensitivity to ultraviolet rays and predisposing to...

    H. Bencharef, M. Lamchahab, ... A. Quessar in Journal of Medical Case Reports
    Article Open access 26 August 2021
  15. Myeloid sarcoma with RBM15::MRTFA (MKL1) mimicking vascular neoplasm

    Extramedullary involvement of acute myeloid leukemia (AML), aka myeloid sarcoma, is a rare phenomenon in acute megakaryoblastic leukemia with RBM15::...

    Fatma Gündoğdu, Abbas Agaimy, ... Kemal Kösemehmetoğlu in Virchows Archiv
    Article Open access 20 February 2024
  16. Measurable residual disease study through three different methods can anticipate relapse and guide pre-emptive therapy in childhood acute myeloid leukemia

    Purpose

    Although outcomes of children with acute myeloid leukemia (AML) have improved over the last decades, around one-third of patients relapse....

    Eduardo Ramos Elbal, José Luis Fuster, ... Alfredo Minguela in Clinical and Translational Oncology
    Article 04 January 2023
  17. Evaluation of the HOXA9 and MEIS1 genes as a potential biomarker in adult acute myeloid leukemia

    Background

    Acute myeloid leukemia (AML) is a heterogeneous disorder encompassing a set of hematopoietic tumors that develop when the myeloid precursor...

    Amira M. N. Abdelrahman, Fetnat Mahmoud Tolba, ... Naglaa M. Hassan in Egyptian Journal of Medical Human Genetics
    Article Open access 23 January 2023
  18. The abundance of the short GATA1 isoform affects megakaryocyte differentiation and leukemic predisposition in mice

    Transcription factor GATA1 controls the delicate balance between proliferation, differentiation and apoptosis in both the erythroid and...

    Daishi Ishihara, Atsushi Hasegawa, ... Ritsuko Shimizu in Experimental Hematology & Oncology
    Article Open access 26 February 2024
Did you find what you were looking for? Share feedback.